Bay Street News, 2024

  – Longevity Biomedical, Inc. is focused on developing and acquiring new technologies spanning therapeutics, health monitoring and digital health […]

CALGARY, Alberta, Sept. 20, 2024 (GLOBE NEWSWIRE) — DIRTT Environmental Solutions Ltd. (“DIRTT”) (TSX: DRT) (OTC: DRTTF) announced today the […]

NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) — Minerals Technologies Inc. (NYSE: MTX) announced participation in Gabelli Funds PFAS Symposium in […]

LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO JULY 31, 2024 Vancouver, September 20, 2024– Leading Edge Materials Corp. (“Leading Edge […]

THIS NEWS RELEASE IS NOT FOR DISTRIBUTIONIN THE UNITED STATES OR TO U.S. NEWS AGENCIES HONG KONG, Sept. 20, 2024 […]

MIPLYFFA is the first FDA-approved treatment for Niemann-Pick disease type C (NPC), an ultra-rare and progressive neurodegenerative disease MIPLYFFA is […]

TAMPA, FL and COMMACK, NY, Sept. 20, 2024 (GLOBE NEWSWIRE) — TRxADE Health, Inc. (“TRxADE”) (NASDAQ: MEDS) and Scienture, LLC […]

VANCOUVER, British Columbia, Sept. 20, 2024 (GLOBE NEWSWIRE) — Giga Metals Corporation (TSX.V: GIGA, OTCQX: GIGGF), a junior mining company […]

Weekly Report (September 13-19, 2024) Third Tranche of Stellantis 2024 Share Buyback Program AMSTERDAM, September 20, 2024 – Stellantis N.V. (“Stellantis” […]

MINEOLA, N.Y., Sept. 20, 2024 (GLOBE NEWSWIRE) — Michael P. Puorro, Chairman and Chief Executive Officer of Hanover Bancorp, Inc. […]